Gelonghui September 22nd, some investors asked Sunshine Nuohe (688621.SH): Hello! What are the competitors of the company, and how can the company break the situation in the face of the encirclement and suppression of the competitors?
Yang Guang Nuo and reply: Hello, dear investors! At present, the company's main competitors in the industry are Tigermed, Medisi, Northrop, Baicheng Pharmaceutical and other listed companies. Compared with other competitors in the same industry, the company is in a competitive advantage in the characteristics of some core technologies.
Centering on the pre-clinical plus clinical research integration strategy, the company continues to deepen the integration development, extending the current integration advantages from chemical drugs to the fields of biological drugs, traditional Chinese medicine and medical devices, and carrying out horizontal expansion; at the same time, the company continues to promote the variety self-research reserve strategy to further improve the transformation of technological achievements.
In the face of the increasingly competitive market, the company will firmly grasp the development opportunities of the domestic pharmaceutical R & D service industry and strengthen its professional service capabilities in the fields of chemical drugs, biological drugs, traditional Chinese medicine and medical devices. consolidate the company's market position in the industry and further improve the company's market share in the domestic market by providing high-quality and omni-directional services. Thank you!